Biktarvy is a complete single tablet regimen for HIV-1 treatment. In the US, it costs $3,700 for a 30-day supply. In Canada, it's around CAD 1,400, and in India, INR 20,000 ($270). These prices were sourced from NIH and JAMA publications. Biktarvy's availability at different price points makes it accessible to those who need it most.
